130 related articles for article (PubMed ID: 25511624)
1. Circuit life versus bleeding risk: the impact of achieved activated partial thromboplastin time versus achieved filtration fraction.
MacEwen C; Watkinson P; Winearls C
Ther Apher Dial; 2015 Jun; 19(3):259-66. PubMed ID: 25511624
[TBL] [Abstract][Full Text] [Related]
2. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
[TBL] [Abstract][Full Text] [Related]
3. Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications.
Floroff CK; Palm NM; Steinberg DH; Powers ER; Wiggins BS
Pharmacotherapy; 2017 Apr; 37(4):393-400. PubMed ID: 28107569
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.
Reeves JH; Cumming AR; Gallagher L; O'Brien JL; Santamaria JD
Crit Care Med; 1999 Oct; 27(10):2224-8. PubMed ID: 10548211
[TBL] [Abstract][Full Text] [Related]
5. Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure.
Chua HR; Baldwin I; Bailey M; Subramaniam A; Bellomo R
J Crit Care; 2012 Dec; 27(6):744.e7-15. PubMed ID: 23102533
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy.
Nagarik AP; Soni SS; Adikey GK; Raman A
Saudi J Kidney Dis Transpl; 2010 May; 21(3):478-83. PubMed ID: 20427872
[TBL] [Abstract][Full Text] [Related]
7. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
Zarbock A; Küllmar M; Kindgen-Milles D; Wempe C; Gerss J; Brandenburger T; Dimski T; Tyczynski B; Jahn M; Mülling N; Mehrländer M; Rosenberger P; Marx G; Simon TP; Jaschinski U; Deetjen P; Putensen C; Schewe JC; Kluge S; Jarczak D; Slowinski T; Bodenstein M; Meybohm P; Wirtz S; Moerer O; Kortgen A; Simon P; Bagshaw SM; Kellum JA; Meersch M;
JAMA; 2020 Oct; 324(16):1629-1639. PubMed ID: 33095849
[TBL] [Abstract][Full Text] [Related]
8. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of a Calculation-Free Weight-Based Unfractionated Heparin Nomogram With Anti-Xa Level Monitoring Compared With Activated Partial Thromboplastin Time.
Kindelin NM; Anthes AM; Providence SM; Zhao X; Aspinall SL
Ann Pharmacother; 2021 May; 55(5):575-583. PubMed ID: 32964730
[TBL] [Abstract][Full Text] [Related]
10. Polyethyleneimine-treated polyacrylonitrile membrane hemofilter for critically ill patients receiving anticoagulant-free prolonged intermittent renal replacement therapy: a single-center, prospective, self-controlled pilot study.
Su T; Jin Q; Liu Z
BMC Nephrol; 2017 Jun; 18(1):208. PubMed ID: 28666474
[TBL] [Abstract][Full Text] [Related]
11. Effect of body mass index on bleeding frequency and activated partial thromboplastin time in weight-based dosing of unfractionated heparin: a retrospective cohort study.
Bauer SR; Ou NN; Dreesman BJ; Armon JJ; Anderson JA; Cha SS; Oyen LJ
Mayo Clin Proc; 2009 Dec; 84(12):1073-8. PubMed ID: 19955244
[TBL] [Abstract][Full Text] [Related]
12. Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding.
Betjes MG; van Oosterom D; van Agteren M; van de Wetering J
J Nephrol; 2007; 20(5):602-8. PubMed ID: 17918147
[TBL] [Abstract][Full Text] [Related]
13. Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin.
Anand SS; Yusuf S; Pogue J; Ginsberg JS; Hirsh J;
Circulation; 2003 Jun; 107(23):2884-8. PubMed ID: 12796128
[TBL] [Abstract][Full Text] [Related]
14. Heparin dosing in critically ill patients undergoing therapeutic hypothermia following cardiac arrest.
Wahby KA; Jhajhria S; Dalal BD; Soubani AO
Resuscitation; 2014 Apr; 85(4):533-7. PubMed ID: 24361456
[TBL] [Abstract][Full Text] [Related]
15. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients.
Tan HK; Baldwin I; Bellomo R
Intensive Care Med; 2000 Nov; 26(11):1652-7. PubMed ID: 11193272
[TBL] [Abstract][Full Text] [Related]
16. Discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin.
Price EA; Jin J; Nguyen HM; Krishnan G; Bowen R; Zehnder JL
Ann Pharmacother; 2013 Feb; 47(2):151-8. PubMed ID: 23386070
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of hemofiltration without anticoagulation in critically ill patients at high risk of bleeding].
Yang RL; Liu DW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):651-5. PubMed ID: 18051723
[TBL] [Abstract][Full Text] [Related]
18. Variables associated with circuit life span in critically ill patients undergoing continuous renal replacement therapy: a prospective observational study.
Zhang Z; Ni H; Lu B
ASAIO J; 2012; 58(1):46-50. PubMed ID: 22210650
[TBL] [Abstract][Full Text] [Related]
19. Conventional coagulation and thromboelastograph parameters and longevity of continuous renal replacement circuits.
Holt AW; Bierer P; Glover P; Plummer JL; Bersten AD
Intensive Care Med; 2002 Nov; 28(11):1649-55. PubMed ID: 12415456
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis.
Lauzier F; Arnold DM; Rabbat C; Heels-Ansdell D; Zarychanski R; Dodek P; Ashley BJ; Albert M; Khwaja K; Ostermann M; Skrobik Y; Fowler R; McIntyre L; Nates JL; Karachi T; Lopes RD; Zytaruk N; Finfer S; Crowther M; Cook D
Intensive Care Med; 2013 Dec; 39(12):2135-43. PubMed ID: 23942857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
